procarbazine has been researched along with Blindness in 1 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sangave, A | 1 |
Faia, LJ | 1 |
Yeh, S | 1 |
Chan, CC | 1 |
Nussenblatt, RB | 1 |
Sen, HN | 1 |
1 other study available for procarbazine and Blindness
Article | Year |
---|---|
A case of rapid progression and vision loss in a patient with primary intraocular lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blindness; Disease Progression; Eye Neoplasms; | 2010 |